...
首页> 外文期刊>Acta Neurochirurgica >Solitary fibrous tumor of the central nervous system: A clinicopathologic study of 24 cases
【24h】

Solitary fibrous tumor of the central nervous system: A clinicopathologic study of 24 cases

机译:中枢神经系统孤立性纤维瘤:24例临床病理研究

获取原文
获取原文并翻译 | 示例
           

摘要

Objective: Solitary fibrous tumor is a rare, spindle-cell benign mesenchymal neoplasm and has a high recurrence rate. In this study, we reviewed our experience in the diagnosis and treatment of 24 patients with central nervous system solitary fibrous tumors. Methods: Clinical data were retrieved from the medical records. Prognosis was assessed by clinic service and telephone interview. The specimens were stained with hematoxylin and eosin. Immunohistochemistry for CD34, CD99, EMA, HMB-45, Bcl-2, vimentin, GFAP, S-100, MBP, CK and MIB-1 was performed in all cases. Distributions of time to progression and recurrence were estimated using the Kaplan-Meier method and compared using the log-rank test. Results: The 24 patients included 13 men and 11 women with a median age of 49.0 years. The most frequent initial symptoms were headache, dizziness, unstable walk and hearing loss. The most common location was cerebellar pontine angle (n∈=∈6). Surgery reached gross total removal for 18 patients but subtotal removal for six patients on initial operation. Histopathologic examination showed spindle to oval cells were disposed in wavy fascicles between prominent, eosinophilic bands of collagen. Dense bands of collagen appeared in cross section as minute nodules that separated individual tumor cells. Cellular areas with a partial hemangiopericytoma pattern were noted in six cases. Atypical presentations were shown on initial operation in three cases. CD34, CD99 and vimentin were 100% positive; but EMA, CK, MBP, HBM-45 and GRAP were 100% negative. The positive in Bcl-2, RF and S-100 was 89%, 85% and 26%, respectively. Follow-up information was available for 23 patients. The median follow-up period was 36.0 months. Nine patients recurred and one patient died from the progression. Incomplete surgical resection was significantly associated with recurrence (p∈=∈0.010). MIB-1 labeling index in recurrence was higher than in no recurrence (6.0% versus 3.4%, p∈=∈0.029). All treated with subtotal removal only had subsequent tumor recurrence or progression; however, the two patients who were administered adjuvant radiosurgery after subtotal removal did not recur or progress. Adjuvant radiosurgery seemed to improve the prognosis (p∈=∈0.028). Conclusions: Solitary fibrous tumor is a rare mesenchymal tumor with a propensity to recur. The most affected area is the cerebellopontine angle. Immunohistochemistry should be used to differentiate solitary fibrous tumor from other tumors. The extent of resection, MIB-1 labeling index and some anaplastic features might be predictive for recurrence. Postoperative radiosurgery might be an option in incompletely resected solitary fibrous tumor. Regular and long-term follow-up remains mandatory to monitor recurrence.
机译:目的:孤立性纤维瘤是一种罕见的纺锤状细胞良性间质瘤,复发率高。在这项研究中,我们回顾了我们在24例中枢神经系统孤立性纤维瘤患者的诊断和治疗中的经验。方法:从病历中检索临床数据。通过临床服务和电话采访评估预后。标本用苏木精和曙红染色。在所有情况下均进行了CD34,CD99,EMA,HMB-45,Bcl-2,波形蛋白,GFAP,S-100,MBP,CK和MIB-1的免疫组织化学。使用Kaplan-Meier方法估算进展和复发时间的分布,并使用对数秩检验进行比较。结果:24名患者包括13名男性和11名女性,中位年龄为49.0岁。最常见的初始症状是头痛,头晕,行走不稳和听力下降。最常见的位置是小脑桥脑角(n∈=ε6)。初次手术时,手术总切除量为18例,但次全切除术为6例。组织病理学检查显示纺锤形至卵形细胞位于胶原的嗜酸性嗜酸性带之间的波浪状束中。密集的胶原蛋白带以横截面的形式出现,微小的小结节将单个肿瘤细胞分开。在六例病例中发现了带有部分血管内皮细胞瘤模式的细胞区域。在3例初次手术中显示了非典型表现。 CD34,CD99和波形蛋白为100%阳性;但EMA,CK,MBP,HBM-45和GRAP均为100%阴性。 Bcl-2,RF和S-100的阳性率分别为89%,85%和26%。有23位患者的随访信息。中位随访期为36.0个月。 9名患者复发,1名患者死于进展。手术切除不完全与复发率显着相关(p∈=∈0.010)。复发时的MIB-1标记指数高于未复发者(6.0%vs 3.4%,p∈=∈0.029)。所有接受大部切除的治疗仅具有随后的肿瘤复发或进展。然而,在小计切除后进行辅助放射外科治疗的两名患者没有复发或进展。辅助放射外科似乎可以改善预后(p∈=∈0.028)。结论:孤立性纤维瘤是一种罕见的间质瘤,具有复发的倾向。受影响最大的区域是小脑桥脑角。免疫组织化学应用于区分孤立性纤维性肿瘤与其他肿瘤。切除的程度,MIB-1标记指数和某些间变性特征可能会预测复发。手术切除可能是不完全切除孤立性纤维性肿瘤的一种选择。定期和长期随访仍是强制性措施,以监测复发情况。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号